相关实验视频
Updated: Jan 7, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
低博卢斯频率对1型糖尿病青少年自动胰岛素输送系统性能的影响
Prerana Chatty1, Sonia Gera1, Andrew Rearson1
1Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA.
Diabetes care
|December 11, 2025
概括
与Omnipod 5 (OP5) 相比,Tandem Control-IQ (CIQ) 自动化胰岛素输送 (AID) 系统在具有低玻尿酸频率的年轻人中显示出更高的范围时间 (TIR). CIQ通过增加AID使用和AID启动的螺栓实现了更高的TIR.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病 技术 技术
- 儿科内分泌学 儿科内分泌学
背景情况:
- 自动注射胰岛素 (AID) 系统为1型糖尿病提供先进的血糖控制.
- 在特定用户群体中优化AID性能至关重要,比如那些有低球频率的用户群体.
研究的目的:
- 为了比较Omnipod 5 (OP5) 和Tandem Control-IQ (CIQ) AID系统之间的范围内时间 (TIR).
- 调查年轻人每日胰岛素注射量要求较低的AID系统性能差异.
主要方法:
- 一项回顾性研究包括202名患有1型糖尿病的青少年,他们使用OP5或CIQ,90天平均每天≤3.0个囊.
- 倾向性得分匹配用于创建可比较的组,控制基线特征.
- 一个多重线性回归模型分析了两个AID系统之间的TIR差异.
主要成果:
- 在倾向分数匹配 (n=98) 后,CIQ用户在AID上花费的时间显著增加 (80.0%对 64.0%,P=0.01).
- 两组之间每天使用者发起的玻尿酸剂量 (每天2.2玻尿酸剂) 没有显著差异.
- 与OP5用户相比,CIQ用户的调整TIR显著更高 (54.9%与46.9%,P=0.002),占绝对增长8.0%.
结论:
- 在患有1型糖尿病的年轻人中,每天需要≤3.0个螺栓,CIQ系统与OP5相比,CIQ系统与优越的TIR有关.
- 增加AID和AID发起的球体的时间可能有助于在这个队列中观察到CIQ的增强血糖控制.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
644
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
644
Insulin Formulations: Types and Delivery
597
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
597
One-Compartment Open Model for IV Bolus Administration: General Considerations
649
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
649
Two-Compartment Open Model: IV Bolus Administration
1.0K
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
1.0K
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
374
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
374
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
209
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
209

